 |
The University of Memphis Expert List is a source for media needing subject experts
to provide commentary on or analysis of news events and other topics.
Many of the faculty listed are also available for speaking engagements - look for
the "Speakers Bureau" designation.
To use the site, browse or search for a specific subject area or a specific faculty
member.
List Experts | List Subjects | List Experts by Subject
|
|
|
Kevin BoggsDir Tech Transfer and Res Dev, FedEx Institute of Technology
Campus: Main
Email: kpboggs@memphis.edu
Office Phone: (901) 678-1712
Areas of Expertise:
Entrepreneurship
Technology Commercialization at the U of M
Technology entrepreneurship
Note: Available for Speakers Bureau contacts only.
About the Expert:
Kevin P. Boggsrnrn365 Innovation Dr. kpboggs@memphis.edu (W) (901) 678-1712 Memphis, TN 38152 (M) (901) 201-9062rnrnrnEmployment HistoryrnrnUniversity of Memphis 1/2008 – PresentrnThe University of Memphis has grown its annual research support to over $50MM. The faculty maintains competitive research programs in a wide variety of areas, which makes the University a key source of local and regional technological innovation.rnrnDirector of Technology Transfer and Research Developmentrn1/2008 – PresentrnrnThe major responsibility of the position is to establish and grow a world-class technology transfer office that works closely with UM faculty, with technology-driven companies, and with entrepreneurs and investors, to bring University inventions to the market. These activities, in turn, support further growth of the University’s research success and provide innovative products to benefit the public. rnrnMajor Achievements:rnrn Negotiated and signed four exclusive licenses and optionsrn Received and managed 49 invention disclosuresrn Oversaw filing of 41 patent applicationsrn Made numerous presentations to faculty groups, business forums, government and community leaders.rn Secured designation of the space for a Ventures Lab pre-seed company incubator.rn rnApplied Genetic Technologies Corp. 1/2005 – 10/2007rnAGTC is a clinical stage drug development company with a patent-protected portfolio of innovative therapeutics that utilizes adeno-associated virus vector technology. rnrnDirector of Business Development and IP Managementrn1/2007-10/2007rnAssistant Director of Business Development and IP Managementrn1/2005 – 1/2007rnrnReporting to the CEO, major responsibilities of this position included negotiating IP licenses to support new products as well as those under development, evaluating and recommending new early stage product opportunities to the Board and Senior Management Team, leading the effort to secure funding for new product development and managing the company’s IP portfolio. rnrnrn rnrnBOGGS, Kevin. Page 2rnrnMajor Achievements: rnrn■ Negotiated IP licenses and research grants with corporations and non-profits.rn■ Drafted major revisions to the Business Plan in preparation for Series B venture capital fund raising.rn■ Drafted and submitted successful Orphan Drug applications to the FDA and the EMEA.rn■ Worked with patent counsel on critical patent validity and freedom to operate issues.rn■ Consistently executed responsibilities within budget.rn rnrn rnUniversity of Florida rnOffice of Technology Licensing 2000 – 2005rnThis office, which has been among the leading university licensing offices in the United States, manages a large and diverse IP portfolio generated by a faculty which is awarded over $500M in annual research funding.rn rnAssistant Director, Life Sciencesrn7/2000 – 1/2005rnrnReporting to the Director, the major responsibilities of the position included managing a large IP portfolio including gene therapy, adult stem cells, small molecule therapeutics, advanced materials and research tools. Duties also included marketing technologies to potential licensees, from initiating contact to management of the executed license. The position was responsible for managing a $1M annual patent budget and supervising two members of the staff. rn rnMajor Achievements:rn rn■ Negotiated over 40 licenses with start-ups, large pharmaceutical companies, biotechnology companies, and others. Several included equity to the University of Florida.rn■ Drafted many key improvements to OTL’s standard agreements which were approved by the university’s General Counsel.rn■ Negotiated and managed large numbers of material transfer agreements, confidential disclosure agreements, sponsored research agreements and amendments to existing licenses.rnrnrnSt. Jude Children’s Research Hospital 1993 – 1997rnPost-Doctoral Fellow, Department of BiochemistryrnrnMajor Achievements:rnrn■ National Research Service Award from NIH. rn■ Performed original research that resulted in four papers in peer reviewed journals.rn rnrn rnrnrnrnBOGGS, Kevin. Page 3rnrnContinuing Professional Educationrnrn■ Biotechnology Industry Organization/Licensing Executives Society Advanced Business Development Course, 2006, Düsseldorf Germanyrn■ Harvard Project on Negotiation, Technology Negotiation Course, 2006rn■ Phacilitate Cell and Gene Therapy Annual Conference, 2005rn■ IDC Drug Discovery Technology Annual Meeting, 2004rn■ Gordon Research Conference: Global Technology Transfer, 2003rn■ Association of University Technology Managers (AUTM) Graduate Course, 2003rn■ AUTM Start-Up Business Development Course, 2002.rn rnrnEducationrnrnPh.D. in Molecular and Cellular BiologyrnMedical University of South CarolinarnAdvisor: Maria Buse, M.D.rnDissertation Title: “Role of S,N,-1,2 Diacylglycerol in Insulin-Stimulated Glucose Transport in Rat Skeletal Muscle”rnrnMasters in Business Administration (Marketing Emphasis)rnUniversity of MemphisrnrnBachelor of Science in Microbiology and Cell SciencernUniversity of Florida
|
|
|
|
If you need information on a subject that is not listed, please call 901/678-2843
or e-mail prnews@memphis.edu.
Faculty interested in being a part of the Expert List and/or Speakers Bureau: Sign up now.
Media Resources
|
Facebook 
YouTube 
Twitter